Live Breaking News & Updates on Lead Senior Staff Scientist

Stay updated with breaking news from Lead senior staff scientist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Human organ chips enable COVID-19 drug repurposing


 E-Mail
A Wyss Institute-led collaboration spanning four research labs and hundreds of miles has used the Institute s organ-on-a-chip (Organ Chip) technology to identify the antimalarial drug amodiaquine as a potent inhibitor of infection with SARS-CoV-2, the virus that causes COVID-19.
The Organ Chip-based drug testing ecosystem established by the collaboration greatly streamlines the process of evaluating the safety and efficacy of existing drugs for new medical applications, and provides a proof-of-concept for the use of Organ Chips to rapidly repurpose existing drugs for new medical applications, including future pandemics. The research is reported in
Nature Biomedical Engineering.
While many groups around the world have been testing existing drugs for efficacy against COVID-19 using cultured cells, it is well known that cells grown in a dish do not behave like the cells in a living human body, and many drugs that appear effective in lab studies do not work ....

United States , South Africa , South Korea , Amanda Jiang , Marisa Mcgrath , Rachelle Prantil Baun , Justin Frere , Shu Horiuchi , Ilona Golynker , Longlong Si , Steve Gygi , Wuji Cao , Girija Goyal , Kohei Oishi , Haiqing Bai , Sarah Gilpin , Daisy Hoagland , Benjamin Nilsson Payant , Danni Zhu , Ken Carlson , Robert Haupt , Kambez Benam , Atiq Nurani , Melissa Rodas , James Logue , Rasmus Moller ,